Latest Intravenous immunoglobulin Stories
A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome.
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay on dialysis for years awaiting compatible organs.
A new treatment for hard-to-match kidney transplant patients is providing dramatic survival benefits.
WASHINGTON, May 25, 2011 /PRNewswire-USNewswire/ -- The Immune Deficiency Foundation (IDF) applauds Representatives Kevin Brady (R-TX) and Doris Matsui (D-CA) and Senators John Kerry (D-MA) and Lamar Alexander (R-TN) for introducing H.R. 1845 and S. 960, both entitled the Medicare IVIG Access Act.
CINCINNATI, April 4, 2011 /PRNewswire/ -- CarePoint Partners (CarePoint) today announced at the National Home Infusion Association Annual Conference in Orlando, Florida that it has acquired Infusion Technologies, a provider of home infusion therapies including antibiotics, IVIG, nutrition, the associated nursing services and a variety of specialty injections, with locations in North Miami and Tampa.
KING OF PRUSSIA, Pa., March 21, 2011 /PRNewswire/ -- Data presented by CSL Behring today suggest that treatment with higher dose HizentraÂ® (IgPro 20) correlates with reduced risk of infection and missed school or work among patients with primary immunodeficiencies (PI).
KING OF PRUSSIA, Pa., March 19, 2011 /PRNewswire/ -- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a high degree of accuracy and precision.
LOS ANGELES, Feb. 3, 2011 /PRNewswire/ -- Grifols, Inc. today announced that it has expanded the company's PatientCare Program to offer immune globulins (IVIG) to the Primary Immune Deficiency community (PID).
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.